Verastem Oncology
VSTM
#7565
Rank
$0.29 B
Marketcap
$5.70
Share price
-2.40%
Change (1 day)
-52.42%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2024 (TTM): -$0.14 Billion USD

According to Verastem Oncology 's latest financial reports the company's current earnings are $10 Million USD. a decrease over its 2023 earnings that were of -$87.37 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2024

Annual earnings

Year Earnings Change
2024 -$0.14 Billion49.31%
2023 -$87.37 Million18.36%
2022 -$73.82 Million3.67%
2021 -$71.2 Million5.43%
2020 -$67.54 Million-54.74%
2019 -$0.15 Billion105.99%
2018 -$72.44 Million6.83%
2017 -$67.81 Million86.06%
2016 -$36.44 Million-37.03%
2015 -$57.87 Million8.43%
2014 -$53.37 Million29.52%
2013 -$41.21 Million28.6%
2012 -$32.04 Million133.9%
2011 -$13.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$44.81 Million-65.65%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.11 B-8,618.84%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.16 B-995.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.39 B-3,468.70%๐Ÿ‡ฌ๐Ÿ‡ง UK